Government ContextGovernment Context
ActivityRulesGrantsPress releasesHearingsBills
ViewsAgenciesTopicsOrganizationsCommitteesLegislators
PricingLog inCreate account

Grants

Federal funding opportunities from Grants.gov — still-open first, soonest deadline at the top.

OpenRecently postedLargestOpen only
NIH ▾
All agenciesNIH (12799)NPS (8507)DOS (7615)FWS (4380)CDC (3897)DOD (3786)DOI (3460)OJP (3338)USAID (3074)BLM (3021)USDA (2824)ACF (2160)DOE (1822)HRSA (1747)NASA (1705)ED (1668)DHS (1600)HHS (1505)EPA (1488)USBR (1433)NSF (1312)DOC (1299)DOT (681)COE (680)HUD (636)NEH (621)ETA (606)SAMHSA (606)FDA (528)DOJ (441)FRA (419)PAMS (415)FHWA (255)SBA (251)NEA (237)IHS (228)DOL (202)AHRQ (198)FTA (198)NARA (161)FS (142)IMLS (139)VA (136)CMS (124)CNCS (103)NHTSA (76)EDA (63)NRC (58)ONDCP (55)NOAA (53)
ArchivedNIH

NIDDK Investigator Award to Support Mentoring of Early Career Researchers from Diverse Backgrounds (K26 - Independent Clinical Trial Not Allowed)

Dec 5, 2022
Posted
View opportunity →
ArchivedNIH

NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional)

Dec 5, 2022
Posted
View opportunity →
ArchivedNIH

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)

Dec 2, 2022
Posted
View opportunity →
ArchivedNIH

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional)

Dec 2, 2022
Posted
View opportunity →
ArchivedNIH

Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Dec 2, 2022
Posted
View opportunity →
ArchivedNIH

Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Dec 2, 2022
Posted
View opportunity →
ArchivedNIH

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Dec 2, 2022
Posted
View opportunity →
ArchivedNIH

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Dec 2, 2022
Posted
View opportunity →
ArchivedNIH

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)

Dec 2, 2022
Posted
View opportunity →
ArchivedNIH

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)

Dec 2, 2022
Posted
View opportunity →
ArchivedNIH

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)

Dec 2, 2022
Posted
View opportunity →
ArchivedNIH

Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)

Dec 2, 2022
Posted
View opportunity →